Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Míreanna comhchosúla

• Rapid emergence of effect of atorvastatin on cardiovascular outcomes in the Collaborative Atorvastatin Diabetes Study (CARDS).
  de réir: Colhoun, H, et al.
  Foilsithe / Cruthaithe: (2005)
• Effects of atorvastatin on kidney outcomes and cardiovascular disease in patients with diabetes: an analysis from the Collaborative Atorvastatin Diabetes Study (CARDS).
  de réir: Colhoun, H, et al.
  Foilsithe / Cruthaithe: (2009)
• Baseline characteristics in the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with Type 2 diabetes.
  de réir: Thomason, M, et al.
  Foilsithe / Cruthaithe: (2004)
• Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes.
  de réir: Colhoun, H, et al.
  Foilsithe / Cruthaithe: (2002)
• Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS).
  de réir: Hitman, G, et al.
  Foilsithe / Cruthaithe: (2007)